RhumbLine Advisers’s Apyx Medical APYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,284
| Closed | -$1.72K | – | 4202 |
|
|
2024
Q2 | $1.72K | Hold |
1,284
| – | – | ﹤0.01% | 4198 |
|
|
2024
Q1 | $1.75K | Hold |
1,284
| – | – | ﹤0.01% | 4099 |
|
|
2023
Q4 | $3.36K | Hold |
1,284
| – | – | ﹤0.01% | 4041 |
|
|
2023
Q3 | $4.11K | Hold |
1,284
| – | – | ﹤0.01% | 4015 |
|
|
2023
Q2 | $6.46K | Buy |
+1,284
| New | +$6.46K | ﹤0.01% | 4038 |
|
|
2022
Q2 | – | Sell |
-27,228
| Closed | -$178K | – | 3100 |
|
|
2022
Q1 | $178K | Buy |
27,228
+3,769
| +16% | +$24.6K | ﹤0.01% | 2784 |
|
|
2021
Q4 | $301K | Sell |
23,459
-347
| -1% | -$4.45K | ﹤0.01% | 2702 |
|
|
2021
Q3 | $330K | Buy |
23,806
+1,714
| +8% | +$23.8K | ﹤0.01% | 2729 |
|
|
2021
Q2 | $228K | Sell |
22,092
-17,970
| -45% | -$185K | ﹤0.01% | 2889 |
|
|
2021
Q1 | $387K | Sell |
40,062
-1,905
| -5% | -$18.4K | ﹤0.01% | 2601 |
|
|
2020
Q4 | $302K | Buy |
41,967
+6,594
| +19% | +$47.5K | ﹤0.01% | 2657 |
|
|
2020
Q3 | $167K | Sell |
35,373
-8,254
| -19% | -$39K | ﹤0.01% | 2743 |
|
|
2020
Q2 | $242K | Buy |
43,627
+2,785
| +7% | +$15.4K | ﹤0.01% | 2679 |
|
|
2020
Q1 | $147K | Buy |
40,842
+2,930
| +8% | +$10.5K | ﹤0.01% | 2683 |
|
|
2019
Q4 | $321K | Buy |
37,912
+566
| +2% | +$4.79K | ﹤0.01% | 2558 |
|
|
2019
Q3 | $253K | Buy |
37,346
+6,634
| +22% | +$44.9K | ﹤0.01% | 2656 |
|
|
2019
Q2 | $206K | Buy |
+30,712
| New | +$206K | ﹤0.01% | 2779 |
|